Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J1746 |
Short Description | Inj., ibalizumab-uiyk, 10 mg |
Long Description | Injection, ibalizumab-uiyk, 10 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2019-01-01 |
Date Added | 2019-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
62064012202 | J1746 | Inj., ibalizumab-uiyk, 10 mg | Trogarzo | THERATECHNOLOGIES INC. | 10 MG | 1.33 | 2 | 20 | 40 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 10 MG |
HCPCS/CPT Billing Units | 0.1 |
Total doses ordered | |
Billing Units | 0.1 |
Drug Details
-
Ibalizumab-uiyk is used with other medications to treat human immunodeficiency virus (HIV) infection in adults who have been treated with several other HIV medications in the past and whose HIV could not be successfully be treated with other medications, including their current therapy. Ibalizumab-uiyk is in a class of medications called monoclonal antibodies. It works by blocking HIV from infecting cells in the body. Although ibalizumab-uiyk does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.